The clinical course refl ects the relatively negative character of the disease and also proves that radiation maculopathy is a very resistant disease requiring almost continuous intravitreal therapy..
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The records of a patient who has been treated for radiation retinopathy following the administration of external radiotherapy for Graves ophthalmopathy was reviewed retrospectively.A total of 60 intravitreal injections were administered into the patient’s right eye during a period of 12.5 years (triamcinolone acetonide, pegaptanib, bevacizumab, ranibizumab,afl ibercept,dexamethazone implant) .
📊
Key Findings & Data:Visual acuity of the right eye remained the same as baseline visual acuity of 0.2 with the Snellen chart during the follow up.
💡
Conclusion & Impact:The clinical course refl ects the relatively negative character of the disease and also proves that radiation maculopathy is a very resistant disease requiring almost continuous intravitreal therapy..
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The records of a patient who has been treated for radiation retinopathy following the administration of external radiotherapy for Graves ophthalmopathy was reviewed retrospectively.A total of 60 intravitreal injections were administered into the patient’s right eye during a period of 12.5 years (triamcinolone acetonide, pegaptanib, bevacizumab, ranibizumab,afl ibercept,dexamethazone implant) . Visual acuity of the right eye remained the same as baseline visual acuity of 0.2 with the Snellen chart during the follow up. Macular edema related to radiation retinopathy could not be fully controlled during the course of follow –up . Various agents were administered during the follow-up period due to persistent nature of the macular edema. The clinical course refl ects the relatively negative character of the disease and also proves that radiation maculopathy is a very resistant disease requiring almost continuous intravitreal therapy..
🔖
Cite This Article
KARATAŞ, E., SAATÇİ, A. O. (2022). Radiation Retinopathy; A Journey With Intravitreal Injections Through 12.5 Years of Treatment and Follow-Up. Retina-Vitreus, Cilt: 30 - Sayı: 1, 74–80. https://ajindex.com/articles/589072
Kamrava, M., Lamb, J., & McCannel, T. A. (2013). Ocular Complications of Radiotherapy. Clinical Ophthalmic Oncology, 99-111
Segal S, Sharma S. Ophthaproblem. Radiation retinopathy. Can Fam Physician. 2006;52:175-83
Stevens JT: Roentgen rays and radium in toxic goiter and hyperthyroidism. JAMA 1931; 97:1689-91
Stallard HB. Radiant energy as (a) a pathogenic (b) a therapeutic agent in ophthalmic disorders. Br J Ophthalmol, Monograph Suppl 1933; VI: 70
Gupta A, Dhawahrir-Scala F, Smith A, et al. Radiation retinopathy: case report and review. BMC Ophthalmol. 2007;7:6
Viebahn M, Barricks ME, Osterloh MD. Synergism between diabetic and radiation retinopathy: case report and review. BJO: 629-32
Zamber RW, Kinyoun JL. Radiation Retinopathy. West J Med. 1992;157:530-3
Brown GC, Shields JA, Sanborn G, et al. Ophthalmology. 1982; 89:1494-501
Chacko DC. Considerations in the diagnosis of radiation injury. JAMA. 1981;245:1255-8
Sunness JS. Retina
St Louis: Mosby; 1994. Pregnancy and retinal disease; 1393-403
Maguire AM, Schachat AP. Retina
St Louis: Mosby; 1994. Radiation Retinopathy: 1509-13
Finger PT, Kurli M.: Laser photocoagulation for radiation retino-pathy after ophthalmic plaque radiation therapy. Br J Ophthalmol. 2005;89:730-8
Bakri SJ, Beer PM. Photodynamic therapy for maculopathy due to radiation retinopathy. Eye. 2005;19:795-9
Kocak N, Saatci AO, Arikan G, et al.: Combination of photodynamic therapy, intravitreal triamcinolone injection, and standard laser photocoagulation in radiation retinopathy: a case report. Ann Ophthalmol. 2006;38:243-7
Mason JO 3rd, Albert MA Jr, Persaud TO, et al. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina. 2007;27:903-7
Solano JM, Bakri SJ, Pulido JS. Regression of radiation-induced macular edema after systemic bevacizumab. Can J Ophthalmol. 2007;42:748-9
Barut Selver O, Yaman A, Öner Hakan F, et al. Intravitreal Injection Treatment in Two Cases with Radiation Retinopathy, Retina-Vitreus, 2009;17:136-40
Kinyoun JL, Chittum ME, Wells CG. Photocoagulation treatment of radiation retinopathy. Am J Ophthalmol. 1988;15;105:470-8
Finger PT. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys 2008;70:974-7
Finger Paul T, Chin Kimberly J. Intravitreous Ranibizumab (Lucentis)